ABOUT PHARMA EXCIPIENTS

“The existing circumstance has uncovered some structural weaknesses in the EU’s medicines offer chain plus a higher dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides said. She advisable that supply chain challenges be addressed in an EU pharmaceutical system envisioned to be released by the top o